Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021


HomeHOSPITALSLos Angeles Daily News Readership Names Valley Presbyterian Hospital “Best Hospital” for Sixteenth Consecutive Year

Los Angeles Daily News Readership Names Valley Presbyterian Hospital “Best Hospital” for Sixteenth Consecutive Year

For the sixteenth year in a row, Valley Presbyterian Hospital (VPH) has been awarded the distinction of Best Hospital in the San Fernando Valley by Los Angeles Daily News readers.

“We are honored that the Daily News readers voted us the ‘Best Hospital’ in the Valley sixteen years in a row. Especially in a year where our community faced so many challenges, this award is a recognition that our commitment to their well-being is appreciated.” — Gustavo Valdespino, President and CEO of Valley Presbyterian Hospital.

Valley Presbyterian Hospital first opened its doors over 60 years ago as a small, neighborhood provider. While remaining as independent as in 1958, today VPH has grown into a 350-bed full-service, non-profit community hospital, dedicated to the health and well-being of the diverse and challenged communities of the San Fernando Valley.

The hospital’s enduring goal is to be a vital asset to the community because for VPH, this Valley is not just an area of operation, but their home. And its people are not just patients, they are friends, partners and community. VPH builds the facilities and services specifically focused on the needs of those in their patient community. VPH maintains services that help patients manage and improve their health by providing access to a wide array of education and support. Patients are treated with respect through listening intently so care is more effective. And VPH consistently invests in its people, the most vital asset of all, building greater teamwork and communication that raises the quality of care for all patients.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy